Furosemide

Alternative names

AIS, ANDR_HUMAN, AR, AR8, AU043990, AW743335, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Atherosclerosis, susceptibility to, included, C10orf70, CA 1, CA 12, CA 13, CA 14, CA 2, CA 7, CA IV, CA VA, CA VB, CA-I, CA-II, CA-IX, CA-VI, CA-VII, CA-XII, CA-XIII, CA-XIV, CA13 carbonic anhydrase XIII, CA4, CA5, CA5B, CA6, CA9, CAB, CAC, CAH12_HUMAN, CAH13_HUMAN, CAH14_HUMAN, CAH1_HUMAN, CAH2_HUMAN, CAH4_HUMAN, CAH5B_HUMAN, CAH6_HUMAN, CAH7_HUMAN, CAH9_HUMAN, CAV, CDGSH iron sulfur domain 1, CDGSH iron-sulfur domain-containing protein 1, CISD1_HUMAN, Car 1, Car 2, Car4, Carbonate dehydratase I, Carbonate dehydratase II, Carbonate dehydratase IV, Carbonate dehydratase IX, Carbonate dehydratase VA, Carbonate dehydratase VB, Carbonate dehydratase VI, Carbonate dehydratase VII, Carbonate dehydratase XII, Carbonate dehydratase XIII, Carbonate dehydratase XIV, Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13, Carbonic anhydrase 14, Carbonic anhydrase 2, Carbonic anhydrase 4, Carbonic anhydrase 5B, Carbonic anhydrase 5B, mitochondrial, Carbonic anhydrase 6, Carbonic anhydrase 7, Carbonic anhydrase 9, Carbonic anhydrase A, Carbonic anhydrase B, Carbonic anhydrase B, formerly, Carbonic anhydrase C, Carbonic anhydrase C, formerly, Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase IX, Carbonic anhydrase VA, Carbonic anhydrase VA mitochondrial, Carbonic anhydrase VB, Carbonic anhydrase VB, mitochondrial, Carbonic anhydrase VI, Carbonic anhydrase VII, Carbonic anhydrase XII, Carbonic anhydrase XIII, Carbonic anhydrase XIV, Carbonic dehydratase, Carbonic dehydratase IV, Carbonic dehydratase VII, D10Ertd214e, DHTR, DKFZp686N23123, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 4.2.1.1, EC=4.2.1.1, ECK0125, ER, ER-alpha, ER-beta, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESTR B, Epididymis secretory protein Li 282, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen resistance, included, FLJ20151, FLJ55736, GUSTIN, HDL cholesterol, augmented response of, to hormone replacement, included, HEL-76, HEL-S-282, HUMARA, HYSP1, HsT18816, JW0122, KD, Kennedy disease (KD), MDS029, MGC14684, MGC21256, MGC45260, MN, Membrane antigen MN, MitoNEET, Myocardial infarction, susceptibility to, included, NR3A1, NR3A2, NR3C4, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), OAT1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000236796, OTTHUMP00000236797, OTTHUMP00000236798, OTTHUMP00000236799, Organic anion transporter 1, P54/58N, PAH transporter, PAHT, Para aminohippurate transporter, RCC associated protein G250, RCC-associated antigen G250, RGD1309529, RNESTROR, ROAT1, RP17, Renal cell carcinoma-associated antigen G250, Renal organic anion transporter 1, Retinitis pigmentosa 17 (autosomal dominant), S22A6_HUMAN, SBMA, SMAX1, Salivary carbonic anhydrase, Secreted carbonic anhydrase, Solute carrier family 22 (organic anion transporter) member 6, Solute carrier family 22 member 6, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), T18816, TFM, Testicular Feminization (TFM), Tumor antigen HOM-RCC-3.1.3, UNQ690/PRO1335, ZCD1, Zinc finger CDGSH type domain 1, androgen receptor splice variant 4b, carbonic anhydrase 5A mitochondrial, carbonic anhydrase V mitochondrial, carbonic anhydrase VA mitochondrial1, carbonic anhydrase VI nirs variant 1, carbonic anhydrase VI nirs variant 3, epididymis luminal protein 76, hOAT1, hPAHT, hROAT1, mitochondrial, pMW1, yadF